PetMed Express (NASDAQ:PETS) Raised to “Buy” at StockNews.com

PetMed Express (NASDAQ:PETS) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Tuesday.

PetMed Express Price Performance

Shares of PETS stock opened at $3.04 on Tuesday. The company has a market cap of $62.79 million, a price-to-earnings ratio of 304.30 and a beta of 0.99. The stock’s fifty day moving average price is $3.99 and its 200 day moving average price is $4.49. PetMed Express has a 1-year low of $2.90 and a 1-year high of $6.85.

PetMed Express (NASDAQ:PETS) last released its earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. As a group, equities research analysts anticipate that PetMed Express will post 0.19 earnings per share for the current year.

Hedge Funds Weigh In On PetMed Express

Institutional investors have recently bought and sold shares of the business. Arrowstreet Capital Limited Partnership boosted its holdings in PetMed Express by 26.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 513,381 shares of the company’s stock valued at $2,474,000 after purchasing an additional 107,614 shares during the last quarter. Metavasi Capital LP boosted its stake in shares of PetMed Express by 48.5% in the fourth quarter. Metavasi Capital LP now owns 340,302 shares of the company’s stock worth $1,640,000 after buying an additional 111,194 shares during the last quarter. Geode Capital Management LLC grew its holdings in PetMed Express by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 224,788 shares of the company’s stock worth $1,084,000 after acquiring an additional 3,558 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of PetMed Express by 2.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 216,812 shares of the company’s stock worth $1,045,000 after purchasing an additional 4,410 shares during the period. Finally, Man Group plc increased its holdings in shares of PetMed Express by 5.5% during the 4th quarter. Man Group plc now owns 145,796 shares of the company’s stock valued at $703,000 after purchasing an additional 7,646 shares in the last quarter. 73.33% of the stock is owned by hedge funds and other institutional investors.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.